Seeking Alpha / - 3 hours from now
Priority Pass members can now enjoy XWELL’s exclusive wellness experiences at select international airport spas Priority Pass members can now enjoy XWELL’s exclusive wellness experiences at select international airport spas
Seeking Alpha / - 3 hours from now
Authorization Positions Company to Generate Non-Dilutive, Tax-Free Capital to Support Growth, Innovation, and Sustainable Expansion Authorization Positions Company to Generate Non-Dilutive, Tax-Free Capital to Support Growth, Innovation, and Sustainable Expansion
Seeking Alpha / - 3 hours from now
SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled at University of Wisconsin School of Medicine and Pu...
Seeking Alpha / - 3 hours from now
MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, announced today the pricing of an underwritten public offering of (i) 1,...
Seeking Alpha / - 3 hours from now
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the National Cancer Institute (NCI) wil...
Seeking Alpha / - 3 hours from now
Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion by 2032
Seeking Alpha / - 3 hours from now
SHENZHEN, CHINA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main B...
Seeking Alpha / - 2 hours from now
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its third quarter 2025 financial results on Thursday, November 6, 2025 prior to market opening. Following the release, Knight will hold...
Seeking Alpha / - 2 hours from now
MONTRÉAL, 30 oct. 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), publiera ses résultats financiers du troisième trimestre 2025, ce jeudi 6 novembre 2025 avant l’ouverture du marché. À la suite de...
Seeking Alpha / - 2 hours from now
FIRST NATIONAL CORPORATION REPORTS RECORD THIRD QUARTER 2025 EARNINGS
Seeking Alpha / - 2 hours from now
SANTA CLARA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that it will hold its fourth quarter and fiscal 2025 earnings conference call on Thursday, Nov. 13, 2025, at 4:30 p.m. ET / 1:30 p.m. PT.
Seeking Alpha / - 2 hours from now
DETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced third quarter 2025 reported net income of $115 million, or $1.13 per diluted share. For the third quarter of 2025, Operating Earnings were also $115 million, or $1.13 per diluted share. Adjusted EBITDA for th...
Seeking Alpha / - 2 hours from now
EU commercialization expected in early 2026; U.S. entry and expanded indications to follow as digital-health pioneer advances tissue-integrated biosensor platform
Seeking Alpha / - 2 hours from now
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Argentine affiliate, Laboratorio LKM S.A. has obtained the regulatory approval and has launched MINJUVI® in Argentina. Knig...
Seeking Alpha / - 2 hours from now
MONTRÉAL, 30 oct. 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd'hui que sa filiale argentine, Laboratorio LKM S.A. a obtenu l'autorisation réglementaire et a lancé MINJUVI® en...